REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$72.73
arrow_upward
+0.68%(+0.49) 1D
Oct 28, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$72.65
High
R$72.75
Low
R$72.65
Mkt. cap
83.73B
Avg. vol.
1.12K
Volume
216.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
Open
R$72.65
High
R$72.75
Low
R$72.65
Mkt. cap
83.73B
Avg. vol.
1.12K
Volume
216.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Seeking Alpha
·
9 hours ago
Regeneron Earnings Preview: Dupixent Is Booming, But It's Still Overvalued (NASDAQ:REGN)
Business Insider Africa
·
13 hours ago
New York-listed Regeneron secures $270 million US Ebola order as African outbreak approaches 10,000 infections
Trefis
·
1 day ago
Has Regeneron Stock Become A Different Bet?
Investing.com
·
2 days ago
Regeneron extends Ebola treatment supply deal with US government
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com